Your browser doesn't support javascript.
loading
Screening for extranodal extension in HPV-associated oropharyngeal carcinoma: evaluation of a CT-based deep learning algorithm in patient data from a multicentre, randomised de-escalation trial.
Kann, Benjamin H; Likitlersuang, Jirapat; Bontempi, Dennis; Ye, Zezhong; Aneja, Sanjay; Bakst, Richard; Kelly, Hillary R; Juliano, Amy F; Payabvash, Sam; Guenette, Jeffrey P; Uppaluri, Ravindra; Margalit, Danielle N; Schoenfeld, Jonathan D; Tishler, Roy B; Haddad, Robert; Aerts, Hugo J W L; Garcia, Joaquin J; Flamand, Yael; Subramaniam, Rathan M; Burtness, Barbara A; Ferris, Robert L.
Affiliation
  • Kann BH; Department of Radiation Oncology, Harvard Medical School, Boston, MA, USA; Mass General Brigham Artificial Intelligence in Medicine Program, Boston, MA, USA. Electronic address: benjamin_kann@dfci.harvard.edu.
  • Likitlersuang J; Dana-Farber Cancer Institute/Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA; Mass General Brigham Artificial Intelligence in Medicine Program, Boston, MA, USA.
  • Bontempi D; Dana-Farber Cancer Institute/Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA; Mass General Brigham Artificial Intelligence in Medicine Program, Boston, MA, USA.
  • Ye Z; Dana-Farber Cancer Institute/Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA; Mass General Brigham Artificial Intelligence in Medicine Program, Boston, MA, USA.
  • Aneja S; Department of Therapeutic Radiology, New Haven, CT, USA.
  • Bakst R; Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Kelly HR; Mass Eye and Ear, Mass General Hospital, Boston, MA, USA.
  • Juliano AF; Mass Eye and Ear, Mass General Hospital, Boston, MA, USA.
  • Payabvash S; Department of Radiology, New Haven, CT, USA.
  • Guenette JP; Dana-Farber Cancer Institute/Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Uppaluri R; Dana-Farber Cancer Institute/Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Margalit DN; Dana-Farber Cancer Institute/Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Schoenfeld JD; Dana-Farber Cancer Institute/Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Tishler RB; Dana-Farber Cancer Institute/Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Haddad R; Dana-Farber Cancer Institute/Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
  • Aerts HJWL; Dana-Farber Cancer Institute/Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA; Mass General Brigham Artificial Intelligence in Medicine Program, Boston, MA, USA; Department of Radiology, Maastricht University, Maastricht, Netherlands.
  • Garcia JJ; Department of Pathology, Mayo Clinic, Rochester, MN, USA.
  • Flamand Y; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, ECOG-ACRIN Biostatistics Center, Boston, MA, USA.
  • Subramaniam RM; Department of Radiology and Nuclear Medicine, University of Notre Dame Australia, Sydney, NSW, Australia; Department of Radiology, Duke University, Durham, NC, USA.
  • Burtness BA; Yale School of Medicine, New Haven, CT, USA.
  • Ferris RL; Department of Otolaryngology, University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA.
Lancet Digit Health ; 5(6): e360-e369, 2023 06.
Article in En | MEDLINE | ID: mdl-37087370

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma / Oropharyngeal Neoplasms / Papillomavirus Infections / Deep Learning Type of study: Clinical_trials / Diagnostic_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limits: Humans Language: En Journal: Lancet Digit Health Year: 2023 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma / Oropharyngeal Neoplasms / Papillomavirus Infections / Deep Learning Type of study: Clinical_trials / Diagnostic_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limits: Humans Language: En Journal: Lancet Digit Health Year: 2023 Type: Article